It has been demonstrated that COMMD10 can inhibit invasion and metastasis of colorectal cancer by targeting the p65 nuclear factor-kappaB (NF-kappaB) subunit and reducing its nuclear translocation, which leads to inactivation of the NF-kappaB pathway (Yang et al., 2017). Here, COMMD10 is linked to colorectal cancer.